Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review

Objective: The aim of this research was to systematically review the studies that investigated the economic impact of the pharmaceutical intervention in Brazilian healthcare services. Methods: A systematic search was conducted in the MEDLINE, EMBASE, and LILACS databases to select the economic eval...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gustavo B. TIGUMAN, Ronaldo M. JUNIOR
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2020
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/ee1a2965a6604306bc879a32c548da65
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ee1a2965a6604306bc879a32c548da65
record_format	dspace
spelling	oai:doaj.org-article:ee1a2965a6604306bc879a32c548da652021-11-28T02:44:25ZEconomic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review10.30968/rbfhss.2020.114.05122179-59242316-7750https://doaj.org/article/ee1a2965a6604306bc879a32c548da652020-11-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/512https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: The aim of this research was to systematically review the studies that investigated the economic impact of the pharmaceutical intervention in Brazilian healthcare services. Methods: A systematic search was conducted in the MEDLINE, EMBASE, and LILACS databases to select the economic evaluations published until November 2019. Two independent authors selected the studies, extracted the data, and assessed the methodological quality using the 19-items Consensus on Health Economic Criteria (CHEC-list) instrument and the reporting quality using the 24-items Consolidated Standards of Economic Health Assessment (CHEERS) checklist. Results: Out of the 290 identified articles, 10 met the eligibility criteria. Most studies were conducted in the southeastern region of Brazil (n=7) and significantly differed in design, economic outcome measure, and type of intervention. The majority (n=8) reported that pharmaceutical practice resulted in reduction of costs and clinical benefits to patients. In general, the methodological and the reporting qualities of the studies were low/moderate with an average score at CHEC-list of 10.3 (range: 3-16 points) and at CHEERS of 15.8 (range: 11-21 points). Conclusions: The Brazilian studies indicate that the pharmacist intervention can lead to economic and clinical benefits for healthcare services. The methodological and the reporting qualities of the studies were limiting factors. Gustavo B. TIGUMANRonaldo M. JUNIORSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 11, Iss 4 (2020)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Gustavo B. TIGUMAN Ronaldo M. JUNIOR Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review
description	Objective: The aim of this research was to systematically review the studies that investigated the economic impact of the pharmaceutical intervention in Brazilian healthcare services. Methods: A systematic search was conducted in the MEDLINE, EMBASE, and LILACS databases to select the economic evaluations published until November 2019. Two independent authors selected the studies, extracted the data, and assessed the methodological quality using the 19-items Consensus on Health Economic Criteria (CHEC-list) instrument and the reporting quality using the 24-items Consolidated Standards of Economic Health Assessment (CHEERS) checklist. Results: Out of the 290 identified articles, 10 met the eligibility criteria. Most studies were conducted in the southeastern region of Brazil (n=7) and significantly differed in design, economic outcome measure, and type of intervention. The majority (n=8) reported that pharmaceutical practice resulted in reduction of costs and clinical benefits to patients. In general, the methodological and the reporting qualities of the studies were low/moderate with an average score at CHEC-list of 10.3 (range: 3-16 points) and at CHEERS of 15.8 (range: 11-21 points). Conclusions: The Brazilian studies indicate that the pharmacist intervention can lead to economic and clinical benefits for healthcare services. The methodological and the reporting qualities of the studies were limiting factors.
format	article
author	Gustavo B. TIGUMAN Ronaldo M. JUNIOR
author_facet	Gustavo B. TIGUMAN Ronaldo M. JUNIOR
author_sort	Gustavo B. TIGUMAN
title	Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review
title_short	Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review
title_full	Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review
title_fullStr	Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review
title_full_unstemmed	Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review
title_sort	economic impact of pharmaceutical interventions on healthcare services from brazil: a systematic review
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2020
url	https://doaj.org/article/ee1a2965a6604306bc879a32c548da65
work_keys_str_mv	AT gustavobtiguman economicimpactofpharmaceuticalinterventionsonhealthcareservicesfrombrazilasystematicreview AT ronaldomjunior economicimpactofpharmaceuticalinterventionsonhealthcareservicesfrombrazilasystematicreview
_version_	1718408474133528576

Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review

Ejemplares similares